Nurse Practitioner in Calumet Park, IL Accepting Medicare
3 Nurse Practitioner nurses found. Showing 1 - 3
 Ms. Katarzyna Para, FNP-C Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 12850 S Ashland Ave, Calumet Park, IL 60827 Phone: 708-972-7958 |
Kimberly Fauke Kakooza, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12850 S Ashland Ave, Calumet Park, IL 60827 Phone: 708-972-7958 |
Raegene Hankle, FNP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 12850 S Ashland Ave, Calumet Park, IL 60827 Phone: 708-972-7958 |
News Archive
USAID releases progress report for Feed the Future
USAID Administrator Rajiv Shah last week released the first progress report for the U.S. global food security program, Feed the Future, which "has helped 1.8 million food producers adopt improved technologies or management practices that can lead to more resilient crops, higher yields and increased incomes," IIP Digital reports.
Neura Therapeutik plans to speed up development of abuse-deterrent, generic extended-release opioids
Neura Therapeutik announced today that they will be accelerating the development of their abuse-deterrent brand and generic extended-release opioids.
American PhRMA companies commit $25M in medicines, medical supplies and cash for Haiti relief efforts
As the need for health care assistance mounts after the recent catastrophic earthquake in Haiti, America's pharmaceutical research and biotechnology companies continue to provide help. So far, more than $25 million in medicines, medical supplies and cash have been committed to relief efforts – and that amount is still growing. The total does not include the contributions of PhRMA member company employees and the many companies committed to matching the pledges of their workers.
AAP testimony asks CDC DOH to include periodontal surveillance as part of strategic priorities
The American Academy of Periodontology was recently invited to provide testimony to the Centers for Disease Control and Prevention's Division of Oral Health as part of the strategic planning process for 2011 through 2014.
Psoriasis drug Enbrel to account for less than one-fifth of sales in 2018 overall market
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, owing to increasing competition from other biologic agents, Amgen/Pfizer/Takeda's Enbrel (etanercept)—the leading therapy in the psoriasis drug market in 2008—will account for less than one-fifth of sales in the overall market in 2018. In 2008, Enbrel garnered half of the psoriasis drug market share in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.
› Verified 4 days ago